A recent study by Huang et al. [107] demonstrated that deletion of CaMKK2 in tumor-bearing mice inhibited MDSC expansion and accumulation while promoting the terminal differentiation of myeloid progenitors into more mature cell types such as dendritic cells and M1 macrophages. The gene discussed is CAMKK2; the disease is neoplasm.